Daily propionic acid supplements lowered levels of a nerve damage marker in people with MS, but clinical benefits remain ...

Difficulties finding the right words during speech affect 25% of MS patients, and often occur alongside broader cognitive ...

Mavenclad may help manage coexisting autoimmune diseases alongside MS, potentially reducing the need for extra drugs.

Nanocurcumin was linked to better disability scores in small RRMS trials, but researchers say larger studies are needed.

Certain gut bacteria may influence the odds of developing MS, in part by altering the activity of specific immune cells, ...

An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...

A gene variant tied to more severe MS disability may also correlate with poor cognitive performance in healthy adults, per a ...

MMR and chickenpox vaccines don't raise relapse risk for people with MS, a study found, supporting current vaccination ...

Changes in the upper spinal cord, measured on routine brain MRI, may help flag higher MS progression risk in people with RRMS ...

Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.

A lab study suggests cyclodextrins may help support myelin sheath repair in MS by reducing harmful fat buildup in immune cells.